Clozapine prescription trends in Brazil in the last decade

Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addresse...

Full description

Bibliographic Details
Main Authors: Raffael Massuda, Clarissa S. Gama, Paulo Belmonte-de-Abreu, Helio Elkis, David Freitas de Lucena, Rodrigo Bressan, Cristiano Noto, Ary Gadelha
Format: Article
Language:English
Published: Associação Brasileira de Psiquiatria (ABP) 2022-10-01
Series:Brazilian Journal of Psychiatry
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462022005011204&tlng=en
_version_ 1828142525861330944
author Raffael Massuda
Clarissa S. Gama
Paulo Belmonte-de-Abreu
Helio Elkis
David Freitas de Lucena
Rodrigo Bressan
Cristiano Noto
Ary Gadelha
author_facet Raffael Massuda
Clarissa S. Gama
Paulo Belmonte-de-Abreu
Helio Elkis
David Freitas de Lucena
Rodrigo Bressan
Cristiano Noto
Ary Gadelha
author_sort Raffael Massuda
collection DOAJ
description Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individuals diagnosed with schizophrenia (ICD F20). The objective of this study was to measure the rates of clozapine use in this population in the last decade using Brazilian Ministry of Health data. Methods: Prescriptions made between 2010 and 2020 in all 26 states and the Federal District registered at the Outpatient Information System Database from the Brazilian Health System (SIASUS) were evaluated. Results: A total of 25,143,524 prescriptions were recorded in this period, with clozapine representing 8.86% of all antipsychotics. The most frequently prescribed antipsychotic for patients with schizophrenia was olanzapine (35.8%), followed by quetiapine (27.5%). From 2010 to 2020, the rate of clozapine prescriptions in Brazil increased from 7.2% to 10.9%. Conclusions: Despite a slight increase in prescriptions in the last decade, clozapine is still underutilized in Brazil.
first_indexed 2024-04-11T19:41:30Z
format Article
id doaj.art-3aa2b604c5754cb6b4a5eaf03a6d74d1
institution Directory Open Access Journal
issn 1809-452X
language English
last_indexed 2024-04-11T19:41:30Z
publishDate 2022-10-01
publisher Associação Brasileira de Psiquiatria (ABP)
record_format Article
series Brazilian Journal of Psychiatry
spelling doaj.art-3aa2b604c5754cb6b4a5eaf03a6d74d12022-12-22T04:06:41ZengAssociação Brasileira de Psiquiatria (ABP)Brazilian Journal of Psychiatry1809-452X2022-10-0110.47626/1516-4446-2022-2572Clozapine prescription trends in Brazil in the last decadeRaffael Massudahttps://orcid.org/0000-0002-2627-8022Clarissa S. Gamahttps://orcid.org/0000-0003-2235-9690Paulo Belmonte-de-Abreuhttps://orcid.org/0000-0002-2853-2004Helio Elkishttps://orcid.org/0000-0003-0156-7511David Freitas de Lucenahttps://orcid.org/0000-0002-1547-3711Rodrigo Bressanhttps://orcid.org/0000-0002-0868-4449Cristiano Notohttps://orcid.org/0000-0002-2706-9118Ary Gadelhahttps://orcid.org/0000-0002-0993-8017 Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individuals diagnosed with schizophrenia (ICD F20). The objective of this study was to measure the rates of clozapine use in this population in the last decade using Brazilian Ministry of Health data. Methods: Prescriptions made between 2010 and 2020 in all 26 states and the Federal District registered at the Outpatient Information System Database from the Brazilian Health System (SIASUS) were evaluated. Results: A total of 25,143,524 prescriptions were recorded in this period, with clozapine representing 8.86% of all antipsychotics. The most frequently prescribed antipsychotic for patients with schizophrenia was olanzapine (35.8%), followed by quetiapine (27.5%). From 2010 to 2020, the rate of clozapine prescriptions in Brazil increased from 7.2% to 10.9%. Conclusions: Despite a slight increase in prescriptions in the last decade, clozapine is still underutilized in Brazil.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462022005011204&tlng=enClozapineschizophrenia, treatment-resistantantipsychotics
spellingShingle Raffael Massuda
Clarissa S. Gama
Paulo Belmonte-de-Abreu
Helio Elkis
David Freitas de Lucena
Rodrigo Bressan
Cristiano Noto
Ary Gadelha
Clozapine prescription trends in Brazil in the last decade
Brazilian Journal of Psychiatry
Clozapine
schizophrenia, treatment-resistant
antipsychotics
title Clozapine prescription trends in Brazil in the last decade
title_full Clozapine prescription trends in Brazil in the last decade
title_fullStr Clozapine prescription trends in Brazil in the last decade
title_full_unstemmed Clozapine prescription trends in Brazil in the last decade
title_short Clozapine prescription trends in Brazil in the last decade
title_sort clozapine prescription trends in brazil in the last decade
topic Clozapine
schizophrenia, treatment-resistant
antipsychotics
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462022005011204&tlng=en
work_keys_str_mv AT raffaelmassuda clozapineprescriptiontrendsinbrazilinthelastdecade
AT clarissasgama clozapineprescriptiontrendsinbrazilinthelastdecade
AT paulobelmontedeabreu clozapineprescriptiontrendsinbrazilinthelastdecade
AT helioelkis clozapineprescriptiontrendsinbrazilinthelastdecade
AT davidfreitasdelucena clozapineprescriptiontrendsinbrazilinthelastdecade
AT rodrigobressan clozapineprescriptiontrendsinbrazilinthelastdecade
AT cristianonoto clozapineprescriptiontrendsinbrazilinthelastdecade
AT arygadelha clozapineprescriptiontrendsinbrazilinthelastdecade